The Use of Intensive Care in Critically Ill Cancer Haematological Patients: "TRIAL-OH"

Long Term Outcomes in Critically Ill Haematological Patients. The Use of Intensive Care in Critically Ill Cancer Haematological Patients

The purpose of this study is to determine:

• Condition of intensive care unit (ICU) admission in patients with haematological malignancies.
• ICU hospital and up to one year mortality.
• Assessment of post ICU burden and health related quality at 90-d and 1 year.

1. To identify prognostic factors of short and medium term mortality, by underlining the respective weights of organ dysfunction and characteristics of underlined malignancy
2. Evaluate the health related quality of life of intensive care survivors(SF36)
3. Impact of intensive care on families burden (HADS, IES).
4. Assess clinicians' satisfaction ( intensivists, haematologists and intensive care nurses) in relation to medical decision-making.
5. Establish the relevance of antifungal treatments.

Inclusion Criteria:

• Hematological malignancies
• hospitalization in ICU
• age >= 18 years

Exclusion Criteria:

• Patients who have already participated to TRIAL-OH